Does AMISULPRIDE Cause Therapeutic product effect incomplete? 200 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 200 reports of Therapeutic product effect incomplete have been filed in association with AMISULPRIDE (Barhemsys). This represents 6.4% of all adverse event reports for AMISULPRIDE.
200
Reports of Therapeutic product effect incomplete with AMISULPRIDE
6.4%
of all AMISULPRIDE reports
0
Deaths
163
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From AMISULPRIDE?
Of the 200 reports, 163 (81.5%) required hospitalization, and 3 (1.5%) were considered life-threatening.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMISULPRIDE. However, 200 reports have been filed with the FAERS database.
What Other Side Effects Does AMISULPRIDE Cause?
Drug ineffective (665)
Weight increased (346)
Toxicity to various agents (305)
Suicide attempt (261)
Akathisia (252)
Extrapyramidal disorder (226)
Drug abuse (219)
Leukopenia (218)
Off label use (191)
Schizophrenia (188)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which AMISULPRIDE Alternatives Have Lower Therapeutic product effect incomplete Risk?
AMISULPRIDE vs AMITRIPTYLINE
AMISULPRIDE vs AMITRIPTYLINE\PERPHENAZINE
AMISULPRIDE vs AMIVANTAMAB
AMISULPRIDE vs AMIVANTAMAB-VMJW
AMISULPRIDE vs AMLODIPINE